US FDA approves Merck’s Ervebo (Ebola Zaire vaccine, live) for use in children 12 months of age and older

3 August 2023 - Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease. ...

Read more →

FDA continues to advance medicines for children

27 October 2022 - Increasing the availability of safe and effective medicines for children is a key priority for the US ...

Read more →

Health Canada grants market authorisation for Kalydeco (ivacaftor) in children ages 12 to <24 months with certain mutations in the CFTR gene

28 January 2019 - Kalydeco is the first and only approved medicine in Canada to treat the underlying cause of ...

Read more →

Ipsen announces FDA approval of Dysport (abobotulinumtoxinA) for injection for the treatment of lower limb spasticity in children aged two and older

1 August 2016 - First and only FDA-approved botulinum toxin for the treatment of pediatric lower limb spasticity. ...

Read more →